Literature DB >> 25875701

Late-Onset Disseminated Mycobacterium avium intracellulare Complex Infection (MAC), Cerebral Toxoplasmosis and Salmonella Sepsis in a German Caucasian Patient with Unusual Anti-Interferon-Gamma IgG1 Autoantibodies.

Leif G Hanitsch1, Madlen Löbel, Holger Müller-Redetzky, Mariana Schürmann, Norbert Suttorp, Nadine Unterwalder, Ulrike Mönnich, Christian Meisel, Kirsten Wittke, Hans-Dieter Volk, Carmen Scheibenbogen, Uwe Kölsch.   

Abstract

PURPOSE: Since we described for the first time a patient with IgG4 autoantibodies to IFN-γ more than 10 years ago, many patients with IFN-γ IgG4 autoantibodies have been described, mostly in Mongolian/ Asian patients with a particular HLA background and in association with disseminated nontuberculous mycobacterial infections. Very recently, the first Caucasian US patient was reported and we now present the case of a 65-year old Caucasian woman with severe disseminated Mycobacterium avium infection, cerebral toxoplasmosis and salmonella sepsis who was tested positive for IFN-γ deficiency due to unusual anti-IFN-γ IgG1 autoantibodies.
METHODS: IFN-γ production after ex vivo ConA stimulation of the patient's whole blood and isolated peripheral blood mononuclear cells was assessed. Anti-human IFN-γ antibodies were measured by Ig/Ig-subclass-specific ELISA. In vitro physiologic relevance and blocking capacity of IFN-γ-stimulation by patient's serum was analysed by flow cytometric assessment of cytokine-induced phosphorylation of pSTAT1(Y701).
RESULTS: Severely impaired IFN-γ production in the patient's whole blood but normal production in peripheral blood mononuclear cells in the absence of autologous serum was observed. High titre anti-IFN-γ antibodies of the IgG1 subclass could be demonstrated in the patient's serum by ELISA. Further, the addition of patient's serum to IFN-γ-stimulated immune cells showed inhibition of STAT1 phosphorylation.
CONCLUSIONS: IFN-γ autoantibodies of any IgG-isotype should be considered in patients with severe opportunistic infections independent of age at onset and ethnicity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25875701     DOI: 10.1007/s10875-015-0161-5

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  19 in total

1.  Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infection.

Authors:  Sarah K Browne; Rifat Zaman; Elizabeth P Sampaio; Kamonwan Jutivorakool; Lindsey B Rosen; Li Ding; Minjal J Pancholi; Lauren M Yang; Debra Long Priel; Gulbu Uzel; Alexandra F Freeman; Carlton E Hayes; Roger Baxter; Stuart H Cohen; Steven M Holland
Journal:  Blood       Date:  2012-03-08       Impact factor: 22.113

2.  Disseminated penicilliosis, recurrent bacteremic nontyphoidal salmonellosis, and burkholderiosis associated with acquired immunodeficiency due to autoantibody against gamma interferon.

Authors:  Bone Siu-Fai Tang; Jasper Fuk-Woo Chan; Min Chen; Owen Tak-Yin Tsang; M Y Mok; Raymond Wai-Man Lai; Rodney Lee; Tak-Lun Que; Herman Tse; Iris Wai-Sum Li; Kelvin Kai-Wang To; Vincent Chi-Chung Cheng; Eric Yuk-Tat Chan; Bojian Zheng; Kwok-Yung Yuen
Journal:  Clin Vaccine Immunol       Date:  2010-05-05

Review 3.  Anti-interferon-γ autoantibody and opportunistic infections: case series and review of the literature.

Authors:  T Kampitak; G Suwanpimolkul; S Browne; C Suankratay
Journal:  Infection       Date:  2010-12-03       Impact factor: 3.553

4.  Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections.

Authors:  Smita Y Patel; Li Ding; Margaret R Brown; Larry Lantz; Ted Gay; Stuart Cohen; Lenna A Martyak; Bernard Kubak; Steven M Holland
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

5.  Disseminated Mycobacterium avium complex infection in a patient carrying autoantibody to interferon-γ.

Authors:  Takashi Ishii; Atsuhisa Tamura; Hirotoshi Matsui; Hideaki Nagai; Shinobu Akagawa; Akira Hebisawa; Ken Ohta
Journal:  J Infect Chemother       Date:  2013-02-28       Impact factor: 2.211

6.  Anti-IFN-γ autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection.

Authors:  Chih-Yu Chi; Chen-Chung Chu; Jing-Pei Liu; Chia-Hao Lin; Mao-Wang Ho; Wen-Jyi Lo; Po-Chang Lin; Hung-Jen Chen; Chia-Huei Chou; Jia-Yih Feng; Chang-Phone Fung; Yuh-Pyng Sher; Chi-Yuan Li; Jen-Hsien Wang; Cheng-Lung Ku
Journal:  Blood       Date:  2012-12-13       Impact factor: 22.113

7.  Adult-onset immunodeficiency in Thailand and Taiwan.

Authors:  Sarah K Browne; Peter D Burbelo; Ploenchan Chetchotisakd; Yupin Suputtamongkol; Sasisopin Kiertiburanakul; Pamela A Shaw; Jennifer L Kirk; Kamonwan Jutivorakool; Rifat Zaman; Li Ding; Amy P Hsu; Smita Y Patel; Kenneth N Olivier; Viraphong Lulitanond; Piroon Mootsikapun; Siriluck Anunnatsiri; Nasikarn Angkasekwinai; Boonmee Sathapatayavongs; Po-Ren Hsueh; Chi-Chang Shieh; Margaret R Brown; Wanna Thongnoppakhun; Reginald Claypool; Elizabeth P Sampaio; Charin Thepthai; Duangdao Waywa; Camilla Dacombe; Yona Reizes; Adrian M Zelazny; Paul Saleeb; Lindsey B Rosen; Allen Mo; Michael Iadarola; Steven M Holland
Journal:  N Engl J Med       Date:  2012-08-23       Impact factor: 91.245

8.  Anti-interferon-gamma autoantibody in a patient with disseminated Mycobacterium avium complex.

Authors:  Toshiyuki Koya; Chikako Tsubata; Hiroshi Kagamu; Ken-ichi Koyama; Masachika Hayashi; Katsuhiro Kuwabara; Takui Itoh; Yoshinari Tanabe; Toshinori Takada; Fumitake Gejyo
Journal:  J Infect Chemother       Date:  2009-04-25       Impact factor: 2.211

9.  The first US domestic report of disseminated Mycobacterium avium complex and anti-interferon-γ autoantibodies.

Authors:  Elise O'Connell; Lindsey B Rosen; Richard W LaRue; Valeria Fabre; Michael T Melia; Paul G Auwaerter; Steven M Holland; Sarah K Browne
Journal:  J Clin Immunol       Date:  2014-08-23       Impact factor: 8.542

10.  Cellular immune responses in HIV-negative immunodeficiency with anti-interferon-γ antibodies and opportunistic intracellular microorganisms.

Authors:  Jiraprapa Wipasa; Panuwat Wongkulab; Kriangkrai Chawansuntati; Romanee Chaiwarit; Khuanchai Supparatpinyo
Journal:  PLoS One       Date:  2014-10-20       Impact factor: 3.240

View more
  10 in total

1.  Natural History and Evolution of Anti-Interferon-γ Autoantibody-Associated Immunodeficiency Syndrome in Thailand and the United States.

Authors:  Gloria H Hong; Ana M Ortega-Villa; Sally Hunsberger; Ploenchan Chetchotisakd; Siriluck Anunnatsiri; Piroon Mootsikapun; Lindsey B Rosen; Christa S Zerbe; Steven M Holland
Journal:  Clin Infect Dis       Date:  2020-06-24       Impact factor: 9.079

2.  Serum Anti-interferon-γ Autoantibody Titer as a Potential Biomarker of Disseminated Non-tuberculous Mycobacterial Infection.

Authors:  Kazutaka Yoshizawa; Ami Aoki; Kenjiro Shima; Yoshinari Tanabe; Toshiyuki Koya; Takashi Hasegawa; Toshiaki Kikuchi; Takuro Sakagami
Journal:  J Clin Immunol       Date:  2020-02-07       Impact factor: 8.317

Review 3.  Laboratory evaluation of the IFN-γ circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease.

Authors:  Ana Esteve-Solé; Ithaisa Sologuren; María Teresa Martínez-Saavedra; Àngela Deyà-Martínez; Carmen Oleaga-Quintas; Rubén Martinez-Barricarte; Andrea Martin-Nalda; Manel Juan; Jean-Laurent Casanova; Carlos Rodriguez-Gallego; Laia Alsina; Jacinta Bustamante
Journal:  Crit Rev Clin Lab Sci       Date:  2018-03-04       Impact factor: 6.250

Review 4.  Minireview: Insights into anti-interferon-γ autoantibodies.

Authors:  Kriangkrai Chawansuntati; Kritsadee Rattanathammethee; Jiraprapa Wipasa
Journal:  Exp Biol Med (Maywood)       Date:  2021-01-11

5.  Juvenile-Onset Immunodeficiency Secondary to Anti-Interferon-Gamma Autoantibodies.

Authors:  Woei-Kang Liew; Koh-Cheng Thoon; Chia-Yin Chong; Natalie W H Tan; Duo-Tong Cheng; Bianca S W Chan; Michelle S Y Ng; Lena Das; Thaschawee Arkachaisri; Chiung-Hui Huang; Jyn-Ling Kuan; Louis Y A Chai; Mark Jean Aan Koh
Journal:  J Clin Immunol       Date:  2019-06-08       Impact factor: 8.542

Review 6.  Disseminated and Congenital Toxoplasmosis in a Mother and Child With Activated PI3-Kinase δ Syndrome Type 2 (APDS2): Case Report and a Literature Review of Toxoplasma Infections in Primary Immunodeficiencies.

Authors:  Djuro Karanovic; Ian C Michelow; Anthony R Hayward; Suk See DeRavin; Ottavia M Delmonte; Michael E Grigg; Adam Kerry Dobbs; Julie E Niemela; Jennifer Stoddard; Zaid Alhinai; Natasha Rybak; Nancy Hernandez; Stefania Pittaluga; Sergio D Rosenzweig; Gulbu Uzel; Luigi D Notarangelo
Journal:  Front Immunol       Date:  2019-02-14       Impact factor: 7.561

Review 7.  Functional Analysis of Anti-cytokine Autoantibodies Using Flow Cytometry.

Authors:  Patricia A Merkel; Terri Lebo; Vijaya Knight
Journal:  Front Immunol       Date:  2019-07-12       Impact factor: 7.561

Review 8.  Anti-Interferon Autoantibodies in Adult-Onset Immunodeficiency Syndrome and Severe COVID-19 Infection.

Authors:  Long-Fang Chen; Cheng-De Yang; Xiao-Bing Cheng
Journal:  Front Immunol       Date:  2021-12-22       Impact factor: 7.561

9.  Case report: Drug rash with eosinophilia and systemic symptoms syndrome in a patient with anti-interferon-γ autoantibody-associated immunodeficiency.

Authors:  Yuxue Nie; Han Wang; Xiying Dong; Siqi Pan; Ting Zhang; Jun Ran; Ying Zhang; Junping Fan; Linqi Zhang; Jinglan Wang
Journal:  Front Immunol       Date:  2022-08-22       Impact factor: 8.786

10.  Treatment Dilemmas in Disseminated Nontuberculous Mycobacterial Infections With Interferon-gamma Autoantibodies.

Authors:  Elizabeth M King; Victoria K Weaver; Mary H Kestler
Journal:  Open Forum Infect Dis       Date:  2021-06-23       Impact factor: 3.835

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.